M.Á. Sánchez-Chaparro

Author

Hospital Clínico Universitario Virgen de la Victoria

Also Known As

M A Sánchez-Chaparro, M. Angel Sanchez-Chaparro, M.-Á. Sánchez-Chaparro, M.A. Sanchez-Chaparro, M.A. Sánchez-Chaparro, M.Á. Sánchez-Chaparro, Miguel A SANCHEZ‐CHAPARRO, Miguel Sánchez-Chaparro, Miguel Ángel Sánchez-Chaparro, Miguel Ángel Sánchez‐Chaparro

Publications

183

Citations

H-Index

Concepts

All Affiliations

Hospital Clínico Universitario Virgen de la Victoria Universidad de Málaga

About

M.Á. Sánchez-Chaparro is an author at Hospital Clínico Universitario Virgen de la Victoria specializing in risk factors, atherosclerosis, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Public Health	1	1	28
2	Epidemiology	1	1	28
3	Global Health	1	1	28
4	Cardiovascular Epidemiology	1	1	28
5	Atherosclerosis	1	1	28

M.Á. Sánchez-Chaparro

Publications

177

Citations

H-Index

Page 1

	Year	Citations
Omega 3 fatty acids induce a marked reduction of apolipoprotein B48 when added to fluvastatin in patients with type 2 diabetes and mixed hyperlipidemia: a preliminary report Pedro Valdivielso, José Rioja, Carlota García-Arias, Cardiovascular Diabetology	2009	72
Lupus-associated endothelial dysfunction, disease activity and arteriosclerosis. Pedro Valdivielso, Juan José Gómez‐Doblas, Melany Moran Macias, PubMed	2009	36
Prevalence of atherogenic dyslipidemia: Association with risk factors and cardiovascular risk in Spanish working population. "ICARIA" study Martha Cabrera, M.Á. Sánchez-Chaparro, Pedro Valdivielso, Atherosclerosis Cardiovascular EpidemiologyCardiovascular DiseaseGlobal HealthCardiovascular RiskHyperlipidemia	2014	28
Evaluation of the chylomicron‐TG to VLDL‐TG ratio for type I hyperlipoproteinemia diagnostic José Rioja, María José Ariza, Natalia García‐Casares, European Journal of Clinical Investigation	2020	26
Atorvastatin in dyslipidaemia of the nephrotic syndrome Pedro Valdivielso, Manuel Moliz, A. Valera, Nephrology	2003	15

Page 1